pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,498
stories
Aug 30, 26
STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
stat
Aug 30, 26
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
stat
Aug 29, 26
Landmark approval for pancreatic cancer; Reactions to Lilly’s Phase 1 secrecy; and more
endpoints
Aug 28, 26
BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer
biospace
Aug 28, 26
Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines
biopharma dive
Aug 28, 26
BioNTech, Genentech terminate Phase 2 of personalized mRNA cancer vaccine
endpoints
Aug 28, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Aug 28, 26
STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
stat
Aug 28, 26
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
fiercebiotech
Aug 28, 26
STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more
stat
Aug 28, 26
Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio
biospace
Aug 28, 26
Roche bets $1B+ on DualityBio's ADC tech to tackle TOPO1 resistance
endpoints
Aug 28, 26
STAT+: Cytokinetics details trial win for what could be its next approval
stat
Aug 28, 26
Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
fiercebiotech
Aug 28, 26
CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own
biospace
Aug 27, 26
STAT+: FDA approves Roivant therapy for rare autoimmune disease
stat
Aug 27, 26
Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company.
biopharma dive
Aug 27, 26
Q&A: Akeso CEO spells out why she thinks its biliary tract cancer data are a big deal
endpoints
Aug 27, 26
Revolution pancreatic cancer drug should quickly become a blockbuster, analysts say
biopharma dive
Aug 27, 26
STAT+: Hospitals plot their response to funding cuts
stat
Aug 27, 26
Moderna's $2B offering; AstraZeneca-Amgen and Biokin chalk up Phase 3 wins
endpoints
Aug 27, 26
What’s in Merck and Moderna’s cancer vaccine algorithm?
stat
Aug 27, 26
Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
fiercebiotech
Aug 27, 26
STAT+: Pharmalittle: We’re reading about a pancreatic cancer drug approval, a Trump deal with biotechs, and more
stat
Aug 27, 26
RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute that
stat
Aug 27, 26
Decoding DEA action on kratom-related substances
stat
Aug 27, 26
STAT+: Cassidy criticizes FDA oversight of abortion pill manufacturers in new report
stat
Aug 27, 26
RevMed could become ‘next oncology titan’ with Rasonque nod
biospace
Aug 27, 26
STAT+: Alnylam’s heart drug troubles take center stage at a cardiology conference
stat
Aug 27, 26
Opinion: I studied Reddit forums on menopause — and found what doctors are missing
stat
← prev
page 17 of 50
next →
